Experiences with cytosine arabinoside in childhood leukaemia and lymphoma.
D000208:Acute Disease; D000293:Adolescent; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D009365:Neoplasm Regression, Spontaneous
D003561:Cytarabine